Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 1,441-1,452 of 4,306
Drug study icon
CompletedNCT00313391

Risperdal Consta and Health Care Utilization in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Atlanta
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 55 Years
Countries
United States
Sponsor
Emory University
Condition
Schizophrenia
Device study icon
CompletedNCT01880255

rTMS for Working Memory Deficits in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Toronto
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 59 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia
Drug study icon
WithdrawnNCT00702793

Safety and Tolerability of Varenicline in Schizophrenia (SATOVA)

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 19 Years to 65 Years
Countries
Sponsor
University of British Columbia
Condition
Schizophrenia
Drug study icon
CompletedNCT01556763

Safety study of EVP-6124 in schizophrenia

This study is completed in the United States. It is testing EVP-6124 for schizophrenia.

In Wichita
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
FORUM Pharmaceuticals Inc
Condition
Schizophrenia
Drug study icon
CompletedNCT01578486

Salsalate as an Adjunctive Treatment for people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Worcester
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Massachusetts, Worcester
Condition
Schizophrenia
Other study type icon
CompletedNCT02921243

Schizophrenia and the Gut Microbiome

This summary needs review. Please check the official study record and contact the research team for details.

In Catonsville
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.From 18 Years to 64 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
Other study type icon
CompletedNCT01001481

Schizophrenia Treatment Adherence Investigation (STAI)

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalOver 18 Years
Countries
Sponsor
Janssen-Cilag Pty Ltd
Condition
Schizophrenia
Other study type icon
CompletedNCT00222807

Schizophrenia, Antipsychotic Treatment and the Risk for Diabetes Mellitus

This summary needs review. Please check the official study record and contact the research team for details.

In Pittsburgh
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalFrom 14 Years to 50 Years
Countries
United States
Sponsor
University of Pittsburgh
Condition
Schizophrenia
Drug study icon
CompletedNCT00178971

Serotonin 1A Agonists and Cognition in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Nashville
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Northwestern University
Condition
Schizophrenia
Drug study icon
CompletedNCT00320697

Smoking Relapse Prevention in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Boston
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
North Suffolk Mental Health Association
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.